查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873661

膝關節切除手術：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Knee Denervation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 97 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球膝關節切除手術市場規模估計為 3.54 億美元，預計到 2031 年將達到 12.53 億美元，在預測期（2025-2031 年）內以 20.3% 的複合年成長率成長。

本報告從跨境產業佈局、資本配置模式、區域經濟相互依存以及供應鏈重組等方面，對近期與膝關節切除手術相關的關稅調整和國際戰略反制措施進行了全面評估。

膝關節神經切除手術是一種微創手術，用於緩解慢性膝關節疼痛，例如骨關節炎引起的疼痛或膝關節關節重建術後的持續性疼痛。此手術選擇性地阻斷將疼痛訊號從膝關節傳遞到大腦的感覺神經，從而在不影響運動功能的情況下維持關節活動度。

骨關節炎（OA）是退化性疾病，可導致關節軟骨退化以及關節邊緣和軟骨下方區域的骨增生。膝骨關節炎（KOA）是四肢關節中最常見的膝關節疾病。根據日本國家統計，超過3%的日本人患有骨關節炎，其中絕大多數為膝骨關節炎。隨著日本社會老化，膝骨關節炎的盛行率正在上升。相關數據顯示，60歲以上族群的盛行率高達12%，且隨著老齡化的成長而呈現上升趨勢。

骨關節炎本質上是退化性疾病，目前尚無臨床治癒方法。膝骨關節炎患者目前主要依靠物理治療、止痛藥和關節內注射等保守治療來控制疼痛並改善生活品質。在藥物治療之前，可採用物理治療、運動治療和減重等支持性治療方法。抗發炎止痛藥通常被認為是膝骨關節炎的第一線治療藥物，但長期使用往往會導致副作用。關節內注射糖皮質激素和透明質酸鈉被認為可以減輕關節內發炎並促進軟骨修復。重複注射可以維持療效，但其療效會在幾年後下降。全膝關節置換術（TKA）被認為是最後有效的治療手段，但部分患者術後效果不佳或術後長期疼痛。由於膝骨關節炎患者迫切需要疼痛治療，膝神經切除手術術的應用引起了人們的關注。

膝關節神經切除手術包括常規射頻消融術（RFA）、脈衝射頻消融術（PRF）、冷卻射頻消融術（CRF）和雷射療法。膝關節神經阻斷技術的原理、參數和療效仍處於早期研究階段，不同調查團隊的技術方法也有顯著差異。然而，對大量臨床試驗和病例報告的系統性評估表明，膝關節神經阻斷術在治療膝骨關節炎（KOA）或全膝關節置換術（TKA）後的術後疼痛方面，可提供長達約一年的鎮痛效果，並改善患者的生活品質，且具有微創、併發症少的優勢。

根據我們的數據，預計2024年全球膝關節切除手術的數量將達到約13萬例，到2025年將達到15.5萬例。未來五年，膝關節切除手術預計將以超過15%的複合年成長率成長，到2030年市場規模將超過1億美元。從地區來看，北美憑藉其完善的醫療設施和先進的技術，將主導膝關節神經切除術市場，到2024年將佔約50%的市場佔有率，其次是歐洲和亞太地區。在技​​術方面，射頻消融術仍然是膝關節切除手術的主要技術，預計到2024年將佔90%以上的市場佔有率。然而，雷射療法（侵入性雷射消融術）等技術正逐步普及並快速發展。

隨著預期壽命的延長，退化性疾病引起的健康問題不可避免地成為重大的健康威脅。膝關節是人體重要的負重關節，慢性疼痛，尤其是膝骨關節炎（KOA），會顯著降低患者的生活品質。中重度或難治性膝骨關節炎患者對傳統治療方法的療效有限，且必須忍受許多副作用。全膝關節置換術（TKA）僅能解決少數患者的問題，而其他患者則手術效果不佳或不適合手術。膝關節切除手術在疼痛治療中展現出良好的療效和較高的安全性，未來具有巨大的市場潛力。

本報告旨在依地區/國家、類型和應用對全球膝關節切除手術市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

膝關節切除手術市場規模、估算和預測以銷售量（單位）和收入（百萬美元）為單位呈現，以2024年為基準年，並包含2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並就膝關節神經切斷術做出明智的商業決策。

市場區隔

公司

  • Boston Scientific
  • Stryker
  • Abbott
  • Avanos Medical（coolief）
  • Cosman Medical
  • Diros Technology
  • Vantage MedTech
  • STARmed America
  • Beijing Neo Science

依類型分類的區隔市場

  • 標準RFA
  • 冷卻射頻消融
  • 其他

應用領域

  • 醫院
  • 診所

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Knee Denervation was estimated to be worth US$ 354 million in 2024 and is forecast to a readjusted size of US$ 1253 million by 2031 with a CAGR of 20.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Knee Denervation cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Knee denervation is a minimally invasive medical procedure designed to reduce chronic knee pain, typically in patients with osteoarthritis or persistent pain following knee surgeries, such as knee replacements. The procedure involves selectively interrupting the sensory nerves that transmit pain signals from the knee to the brain. This is achieved without affecting motor function, thereby preserving joint movement.

Osteoarthritis (OA) is a degenerative disease common in synovial joints, which can cause degeneration of articular cartilage, bone hyperplasia at the joint margin and under the cartilage, etc. Knee osteoarthritis (KOA) is the most common knee disease in the limb joints. Domestic statistics show that more than 3% of people in my country suffer from OA, and KOA accounts for the majority. As my country gradually enters an aging society, the incidence of KOA is higher in the population. According to relevant data, the incidence rate in people over 60 years old is as high as 12%, and it is increasing with age.

KOA is essentially a degenerative disease and cannot be cured clinically. At present, KOA patients mostly use conservative treatments such as physical therapy, analgesics and intra-articular injections to control pain and improve their quality of life. Before drug intervention, there are auxiliary treatment measures such as physical therapy, exercise, and weight loss. It is generally believed that anti-inflammatory analgesics are the first choice for the treatment of KOA, but long-term use often produces adverse reactions. Intra-articular injection of glucocorticoids or sodium hyaluronate is believed to relieve inflammation in the joint and promote cartilage repair. Repeated injections can maintain the efficacy, but the effect will still decline after several years. Total knee arthroplasty (TKA) surgery is considered to be the only effective ultimate solution, but some patients still have poor postoperative effects or long-term postoperative pain. The urgent need for pain treatment in KOA patients has given rise to the application of Knee Denervation technology in this field.

Knee Denervation includes traditional radiofrequency ablation (RFA), pulsed radiofrequency (PRF), cooled RFA (CRF) and laser treatment. The principles, parameters and efficacy of Knee Denervation technology are still in the early stages, which leads to large differences in the technical methods used by different research teams. However, through a systematic evaluation of numerous clinical trials and case reports, it can still be concluded that Knee Denervation can relieve pain and improve quality of life for up to about 1 year in the treatment of postoperative pain after KOA or TKA, and has the advantages of less trauma and fewer complications.

According to our data, the global volume of Knee Denervation surgeries will be around 130,000 in 2024, and the volume is expected to reach 155,000 in 2025. The compound annual growth rate of Knee Denervation will reach more than 15% in the next five years, and the market size will exceed US$100 million by 2030. From a regional perspective, North America occupies a major position in the Knee Denervation industry with its complete medical facilities and advanced technology, with a market share of nearly 50% in 2024, followed by Europe and Asia Pacific. From a technical point of view, the main method of Knee Denervation is radiofrequency ablation, which will account for more than 90% in 2024, but laser therapy (invasive LA) and other methods are gradually showing their advantages and are developing rapidly.

With the extension of life expectancy, the health problems caused by degenerative diseases will inevitably become a major health threat. The knee joint is an important load-bearing joint in the human body. Chronic pain, especially KOA, will seriously reduce the quality of life of patients. Patients with moderate to severe or refractory KOA benefit less from traditional treatments and have to endure many adverse reactions. TKA surgery can only solve the problems of some patients. Some patients still have poor surgical results or do not have the conditions for surgical treatment. Knee Denervation for pain treatment has shown good therapeutic effects and high safety, and has huge market potential in the future.

This report aims to provide a comprehensive presentation of the global market for Knee Denervation, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Knee Denervation by region & country, by Type, and by Application.

The Knee Denervation market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knee Denervation.

Market Segmentation

By Company

  • Boston Scientific
  • Stryker
  • Abbott
  • Avanos Medical (coolief)
  • Cosman Medical
  • Diros Technology
  • Vantage MedTech
  • STARmed America
  • Beijing Neo Science

Segment by Type

  • Standard RFA
  • Cooled RFA
  • Others

Segment by Application

  • Hospital
  • Clinic

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Knee Denervation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Knee Denervation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Knee Denervation in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Knee Denervation Product Introduction
  • 1.2 Global Knee Denervation Market Size Forecast
    • 1.2.1 Global Knee Denervation Sales Value (2020-2031)
    • 1.2.2 Global Knee Denervation Sales Volume (2020-2031)
    • 1.2.3 Global Knee Denervation Sales Price (2020-2031)
  • 1.3 Knee Denervation Market Trends & Drivers
    • 1.3.1 Knee Denervation Industry Trends
    • 1.3.2 Knee Denervation Market Drivers & Opportunity
    • 1.3.3 Knee Denervation Market Challenges
    • 1.3.4 Knee Denervation Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Knee Denervation Players Revenue Ranking (2024)
  • 2.2 Global Knee Denervation Revenue by Company (2020-2025)
  • 2.3 Global Knee Denervation Players Sales Volume Ranking (2024)
  • 2.4 Global Knee Denervation Sales Volume by Company Players (2020-2025)
  • 2.5 Global Knee Denervation Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Knee Denervation Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Knee Denervation Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Knee Denervation
  • 2.9 Knee Denervation Market Competitive Analysis
    • 2.9.1 Knee Denervation Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Knee Denervation Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Denervation as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Standard RFA
    • 3.1.2 Cooled RFA
    • 3.1.3 Others
  • 3.2 Global Knee Denervation Sales Value by Type
    • 3.2.1 Global Knee Denervation Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Knee Denervation Sales Value, by Type (2020-2031)
    • 3.2.3 Global Knee Denervation Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Knee Denervation Sales Volume by Type
    • 3.3.1 Global Knee Denervation Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Knee Denervation Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Knee Denervation Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Knee Denervation Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Clinic
  • 4.2 Global Knee Denervation Sales Value by Application
    • 4.2.1 Global Knee Denervation Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Knee Denervation Sales Value, by Application (2020-2031)
    • 4.2.3 Global Knee Denervation Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Knee Denervation Sales Volume by Application
    • 4.3.1 Global Knee Denervation Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Knee Denervation Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Knee Denervation Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Knee Denervation Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Knee Denervation Sales Value by Region
    • 5.1.1 Global Knee Denervation Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Knee Denervation Sales Value by Region (2020-2025)
    • 5.1.3 Global Knee Denervation Sales Value by Region (2026-2031)
    • 5.1.4 Global Knee Denervation Sales Value by Region (%), (2020-2031)
  • 5.2 Global Knee Denervation Sales Volume by Region
    • 5.2.1 Global Knee Denervation Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Knee Denervation Sales Volume by Region (2020-2025)
    • 5.2.3 Global Knee Denervation Sales Volume by Region (2026-2031)
    • 5.2.4 Global Knee Denervation Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Knee Denervation Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Knee Denervation Sales Value, 2020-2031
    • 5.4.2 North America Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Knee Denervation Sales Value, 2020-2031
    • 5.5.2 Europe Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Knee Denervation Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Knee Denervation Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Knee Denervation Sales Value, 2020-2031
    • 5.7.2 South America Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Knee Denervation Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Knee Denervation Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Knee Denervation Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Knee Denervation Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Knee Denervation Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Knee Denervation Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Knee Denervation Sales Value, 2020-2031
    • 6.3.2 United States Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Knee Denervation Sales Value, 2020-2031
    • 6.4.2 Europe Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Knee Denervation Sales Value, 2020-2031
    • 6.5.2 China Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Knee Denervation Sales Value, 2020-2031
    • 6.6.2 Japan Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Knee Denervation Sales Value, 2020-2031
    • 6.7.2 South Korea Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Knee Denervation Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Knee Denervation Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Knee Denervation Sales Value, 2020-2031
    • 6.9.2 India Knee Denervation Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Knee Denervation Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Boston Scientific
    • 7.1.1 Boston Scientific Company Information
    • 7.1.2 Boston Scientific Introduction and Business Overview
    • 7.1.3 Boston Scientific Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Boston Scientific Knee Denervation Product Offerings
    • 7.1.5 Boston Scientific Recent Development
  • 7.2 Stryker
    • 7.2.1 Stryker Company Information
    • 7.2.2 Stryker Introduction and Business Overview
    • 7.2.3 Stryker Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Stryker Knee Denervation Product Offerings
    • 7.2.5 Stryker Recent Development
  • 7.3 Abbott
    • 7.3.1 Abbott Company Information
    • 7.3.2 Abbott Introduction and Business Overview
    • 7.3.3 Abbott Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Abbott Knee Denervation Product Offerings
    • 7.3.5 Abbott Recent Development
  • 7.4 Avanos Medical (coolief)
    • 7.4.1 Avanos Medical (coolief) Company Information
    • 7.4.2 Avanos Medical (coolief) Introduction and Business Overview
    • 7.4.3 Avanos Medical (coolief) Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Avanos Medical (coolief) Knee Denervation Product Offerings
    • 7.4.5 Avanos Medical (coolief) Recent Development
  • 7.5 Cosman Medical
    • 7.5.1 Cosman Medical Company Information
    • 7.5.2 Cosman Medical Introduction and Business Overview
    • 7.5.3 Cosman Medical Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Cosman Medical Knee Denervation Product Offerings
    • 7.5.5 Cosman Medical Recent Development
  • 7.6 Diros Technology
    • 7.6.1 Diros Technology Company Information
    • 7.6.2 Diros Technology Introduction and Business Overview
    • 7.6.3 Diros Technology Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Diros Technology Knee Denervation Product Offerings
    • 7.6.5 Diros Technology Recent Development
  • 7.7 Vantage MedTech
    • 7.7.1 Vantage MedTech Company Information
    • 7.7.2 Vantage MedTech Introduction and Business Overview
    • 7.7.3 Vantage MedTech Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Vantage MedTech Knee Denervation Product Offerings
    • 7.7.5 Vantage MedTech Recent Development
  • 7.8 STARmed America
    • 7.8.1 STARmed America Company Information
    • 7.8.2 STARmed America Introduction and Business Overview
    • 7.8.3 STARmed America Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 STARmed America Knee Denervation Product Offerings
    • 7.8.5 STARmed America Recent Development
  • 7.9 Beijing Neo Science
    • 7.9.1 Beijing Neo Science Company Information
    • 7.9.2 Beijing Neo Science Introduction and Business Overview
    • 7.9.3 Beijing Neo Science Knee Denervation Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Beijing Neo Science Knee Denervation Product Offerings
    • 7.9.5 Beijing Neo Science Recent Development

8 Industry Chain Analysis

  • 8.1 Knee Denervation Industrial Chain
  • 8.2 Knee Denervation Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Knee Denervation Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Knee Denervation Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Knee Denervation Market Trends
  • Table 2. Knee Denervation Market Drivers & Opportunity
  • Table 3. Knee Denervation Market Challenges
  • Table 4. Knee Denervation Market Restraints
  • Table 5. Global Knee Denervation Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Knee Denervation Revenue Market Share by Company (2020-2025)
  • Table 7. Global Knee Denervation Sales Volume by Company (2020-2025) & (Units)
  • Table 8. Global Knee Denervation Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Knee Denervation Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Knee Denervation Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Knee Denervation Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Knee Denervation
  • Table 13. Global Knee Denervation Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Denervation as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Knee Denervation Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Knee Denervation Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Knee Denervation Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Knee Denervation Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Knee Denervation Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Knee Denervation Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
  • Table 22. Global Knee Denervation Sales Volume by Type (2020-2025) & (Units)
  • Table 23. Global Knee Denervation Sales Volume by Type (2026-2031) & (Units)
  • Table 24. Global Knee Denervation Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Knee Denervation Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Knee Denervation Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Knee Denervation Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Knee Denervation Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Knee Denervation Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Knee Denervation Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Knee Denervation Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Knee Denervation Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Knee Denervation Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
  • Table 34. Global Knee Denervation Sales Volume by Application (2020-2025) & (Units)
  • Table 35. Global Knee Denervation Sales Volume by Application (2026-2031) & (Units)
  • Table 36. Global Knee Denervation Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Knee Denervation Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Knee Denervation Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Knee Denervation Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Knee Denervation Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Knee Denervation Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Knee Denervation Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Knee Denervation Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Knee Denervation Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Knee Denervation Sales Volume by Region (Units): 2020 VS 2024 VS 2031
  • Table 46. Global Knee Denervation Sales Volume by Region (2020-2025) & (Units)
  • Table 47. Global Knee Denervation Sales Volume by Region (2026-2031) & (Units)
  • Table 48. Global Knee Denervation Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Knee Denervation Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Knee Denervation Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Knee Denervation Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Knee Denervation Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Knee Denervation Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Knee Denervation Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Knee Denervation Sales Volume, (2020-2025) & (Units)
  • Table 56. Key Countries/Regions Knee Denervation Sales Volume, (2026-2031) & (Units)
  • Table 57. Boston Scientific Company Information
  • Table 58. Boston Scientific Introduction and Business Overview
  • Table 59. Boston Scientific Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Boston Scientific Knee Denervation Product Offerings
  • Table 61. Boston Scientific Recent Development
  • Table 62. Stryker Company Information
  • Table 63. Stryker Introduction and Business Overview
  • Table 64. Stryker Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Stryker Knee Denervation Product Offerings
  • Table 66. Stryker Recent Development
  • Table 67. Abbott Company Information
  • Table 68. Abbott Introduction and Business Overview
  • Table 69. Abbott Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Abbott Knee Denervation Product Offerings
  • Table 71. Abbott Recent Development
  • Table 72. Avanos Medical (coolief) Company Information
  • Table 73. Avanos Medical (coolief) Introduction and Business Overview
  • Table 74. Avanos Medical (coolief) Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Avanos Medical (coolief) Knee Denervation Product Offerings
  • Table 76. Avanos Medical (coolief) Recent Development
  • Table 77. Cosman Medical Company Information
  • Table 78. Cosman Medical Introduction and Business Overview
  • Table 79. Cosman Medical Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Cosman Medical Knee Denervation Product Offerings
  • Table 81. Cosman Medical Recent Development
  • Table 82. Diros Technology Company Information
  • Table 83. Diros Technology Introduction and Business Overview
  • Table 84. Diros Technology Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Diros Technology Knee Denervation Product Offerings
  • Table 86. Diros Technology Recent Development
  • Table 87. Vantage MedTech Company Information
  • Table 88. Vantage MedTech Introduction and Business Overview
  • Table 89. Vantage MedTech Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Vantage MedTech Knee Denervation Product Offerings
  • Table 91. Vantage MedTech Recent Development
  • Table 92. STARmed America Company Information
  • Table 93. STARmed America Introduction and Business Overview
  • Table 94. STARmed America Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. STARmed America Knee Denervation Product Offerings
  • Table 96. STARmed America Recent Development
  • Table 97. Beijing Neo Science Company Information
  • Table 98. Beijing Neo Science Introduction and Business Overview
  • Table 99. Beijing Neo Science Knee Denervation Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. Beijing Neo Science Knee Denervation Product Offerings
  • Table 101. Beijing Neo Science Recent Development
  • Table 102. Key Raw Materials Lists
  • Table 103. Raw Materials Key Suppliers Lists
  • Table 104. Knee Denervation Downstream Customers
  • Table 105. Knee Denervation Distributors List
  • Table 106. Research Programs/Design for This Report
  • Table 107. Key Data Information from Secondary Sources
  • Table 108. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Knee Denervation Product Picture
  • Figure 2. Global Knee Denervation Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Knee Denervation Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Knee Denervation Sales Volume (2020-2031) & (Units)
  • Figure 5. Global Knee Denervation Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Knee Denervation Report Years Considered
  • Figure 7. Global Knee Denervation Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Knee Denervation Players Sales Volume Ranking (2024) & (Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Knee Denervation Revenue in 2024
  • Figure 10. Knee Denervation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Standard RFA Picture
  • Figure 12. Cooled RFA Picture
  • Figure 13. Others Picture
  • Figure 14. Global Knee Denervation Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Knee Denervation Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Knee Denervation Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
  • Figure 17. Global Knee Denervation Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Knee Denervation Price by Type (2020-2031) & (US$/Unit)
  • Figure 19. Product Picture of Hospital
  • Figure 20. Product Picture of Clinic
  • Figure 21. Global Knee Denervation Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Knee Denervation Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Knee Denervation Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
  • Figure 24. Global Knee Denervation Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Knee Denervation Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Knee Denervation Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Knee Denervation Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Knee Denervation Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Knee Denervation Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Knee Denervation Sales Volume (%), (2020-2031)
  • Figure 38. United States Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Knee Denervation Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Knee Denervation Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Knee Denervation Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Knee Denervation Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Knee Denervation Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Knee Denervation Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Knee Denervation Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Knee Denervation Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Knee Denervation Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Knee Denervation Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Knee Denervation Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Knee Denervation Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Knee Denervation Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Knee Denervation Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Knee Denervation Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Knee Denervation Industrial Chain
  • Figure 60. Knee Denervation Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed